TREM2-Mediated Cholesterol Efflux in Macrophages Inhibits Anti-Tumor Immunity via Limitation of CD4&lt;sup&gt;+&lt;/sup&gt; T and NK Cells. This evidence concerns the gene TREM2 and neoplasm.